rhodexin A

isolated from Rhodea japonica; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chikahisa-Muramatsu, Lumi: 1 article (05/2003)
2.	Kanemaru, Kaori: 1 article (05/2003)
3.	Masuda, Toshiya: 1 article (05/2003)
4.	Nakao, Hiromi: 1 article (05/2003)
5.	Oyama, Yasuo: 1 article (05/2003)
6.	Toi, Yukiko: 1 article (05/2003)
7.	Umebayashi, Chisato: 1 article (05/2003)
8.	Yamamoto, Natsuko: 1 article (05/2003)

1.	Neoplasms (Cancer) 05/01/2003 - "Rhodexin A may also be a candidate for cancer treatment because there have been clinical reports of tumor regression in patients taking cardiac glycosides."
2.	Leukemia 05/01/2003 - "The results indicate that rhodexin A exerts a potent inhibitory action on the growth of human leukemia K562 cells by inducing cell cycle arrest and apoptosis. " 05/01/2003 - "Flow cytometric estimation of cytotoxic activity of rhodexin A isolated from Rhodea japonica in human leukemia K562 cells." 05/01/2003 - "We have examined the cytotoxic effect of rhodexin A isolated from the extract of Rhodea japonica on human leukemia K562 cells using a flow cytometer and compared it with that of ouabain. "